How VytlAIQ turns pharmacy data into decisions
By Heather Brooks, Vice President, Pharmacy Services Products, VytlOne
How does AI improve pharmacy analytics for health systems? AI connects the data scattered across a health system’s pharmacy programs, from EMRs, third-party administrators, dispensing systems, and patient management platforms to 340B platforms, and normalizes it into one continuously updated view. That lets leaders see performance in real time, catch problems early, spot missed 340B and specialty opportunities, and make strategic decisions from clean data instead of manual reports. VytlAIQ is VytlOne’s AI-powered intelligence platform built to do exactly this for 340B, outpatient retail, specialty, and clinic-owned pharmacy programs.
Health system leaders overseeing 340B programs and outpatient pharmacy operations are managing some of the most complex, data-intensive work in healthcare. They are responsible for seeing that 340B savings flow back to the communities they serve, that outpatient retail and specialty pharmacies are retaining patients, and that clinic-owned pharmacy programs are reaching their full potential. The challenge has never been the availability of data. It has always been the ability to make sense of it quickly enough to act. VytlAIQ gives leaders real-time analytics, predictive insights, and decision-support tools built for exactly that complexity.
The five ways at a glance
- AI unifies data from every pharmacy system into one real-time view.
- AI catches performance signals early, while they are still easy to fix.
- AI surfaces missed 340B, retail, and specialty opportunities.
- AI flags patient leakage before a patient is lost.
- AI supports strategic decisions with clean, interpreted data.
1. AI brings all your pharmacy program data into one platform
Meaningful insight starts with complete data, and for health system pharmacy programs, that data lives in many places at once. A common frustration among pharmacy leaders is how long it takes to get a clear, reliable picture of program performance. Reports are often built manually, arrive on a lag, and require significant interpretation before they can inform a decision. Electronic medical records, third-party administrators, pharmacy dispensing systems, patient management platforms, and 340B platforms each hold a piece of the picture. Without a way to connect them, leaders make decisions on partial information or spend hours manually pulling data before analysis can begin.
VytlAIQ was built to solve that at the foundation. The platform ingests data from all of these source systems, normalizes it, and presents it through a single access point designed for health system pharmacy leadership. Rather than navigating multiple reports from multiple systems, leaders log into one platform and see a unified view of how their 340B, outpatient retail, and specialty pharmacy programs are performing. Because the data is consolidated and continuously updated, the dashboards reflect what is happening now, not what was happening when the last report ran. When something needs attention, it is visible. When programs are on track, that is visible too. The result is a leadership team that spends less time gathering data and more time acting on it.
2. AI turns data signals into early action
In health system pharmacy, the difference between a manageable issue and a major operational problem often comes down to timing. By the time a downward trend appears in a monthly report, the window for easy correction has usually passed. VytlAIQ closes that gap by identifying signals in the data early, while there is still time to act without disruption.
The platform continuously monitors performance indicators across all pharmacy program types, looking for patterns that precede problems rather than documenting them after the fact. A gradual decline in 340B-eligible prescription capture, a slowdown in specialty therapy starts, or a dip in refill adherence at a clinic-owned location are all conditions VytlAIQ can surface before they register as a trend leadership has to explain. When those signals appear, the platform brings them forward with enough context to understand what is happening, where, and what options exist to address it.
That early visibility changes how leadership teams operate. Rather than reacting to performance problems after the fact, they are positioned to make small, targeted adjustments that keep programs on track. Over time, that shift from reactive to proactive management has a meaningful impact on program performance, patient retention, and the financial health of the programs the health system depends on.
3. AI surfaces pharmacy program opportunities you’re missing
Health systems often do not know what they are missing until the data is organized to show them. VytlAIQ uses predictive analytics to identify underutilized opportunities across all three program types: 340B-eligible prescriptions that are not being captured, patients who miss the chance to fill at the health system retail pharmacy, and specialty therapy candidates being referred out of network.
For example, a health system may have a strong oncology program but route specialty patients to an external partner by default rather than capturing them in its own specialty pharmacy. VytlAIQ can identify that pattern, quantify the financial and clinical impact, and help leadership make the case for an operational change. These are not hypothetical opportunities. They are real gaps that exist in most health system pharmacy programs and are difficult to see without the right analytical lens.
4. AI spots patient leakage before it becomes a loss
Patient leakage occurs when a patient fills a prescription outside the health system’s pharmacy network. It is one of the most persistent and costly challenges pharmacy leaders face, and historically, identifying it required manual data pulls and retrospective analysis that arrived too late to act on.
VytlAIQ changes that by continuously analyzing patient prescription activity across 340B, outpatient retail, and specialty programs, identifying patterns that signal leakage risk before a patient is lost. For example, a patient discharged from a health system clinic who has not filled a follow-up prescription within an expected window can be flagged automatically, giving the care and pharmacy team a chance to re-engage. For 340B programs specifically, every prescription that leaves the network is a missed opportunity to capture savings that fund critical patient services.
5. AI supports better decisions about your pharmacy programs’ future
The most valuable use of AI in health system pharmacy is not describing what has happened. It is helping leadership decide what comes next. VytlAIQ combines historical performance data, predictive modeling, and the ability to ask the platform a direct question, giving leaders the context to think strategically about their programs. For 340B leaders, that means assessment and planning supported by visibility into program compliance, savings generation, eligible prescription capture rates, and change risk modeling. For outpatient retail and specialty programs, it means fill rates, patient leakage, adherence benchmarks, and revenue performance, plus the unique attributes affecting each.
Whether a health system is evaluating whether to expand its retail pharmacy reach, change its 340B program structure, or invest in specialty pharmacy growth, those decisions benefit from clean, organized, AI-interpreted data. VytlAIQ is designed to meet health system leaders wherever they are, whether managing day-to-day operations or planning three years out.
The future of health system pharmacy is one where AI handles the complexity of data aggregation and pattern recognition, freeing health system, pharmacy, and operational leaders to focus on what only people can do: building relationships, driving strategy, and delivering better outcomes for patients.
Frequently asked questions
What is pharmacy analytics?
Pharmacy analytics is the practice of collecting and interpreting data across a health system’s pharmacy programs, including 340B, outpatient retail, specialty, and clinic-owned, to measure performance, catch risks early, and guide decisions. AI platforms like VytlAIQ consolidate that data into one real-time view.
How does AI help manage 340B programs?
AI connects 340B platform data with dispensing and patient records to track eligible prescription capture, savings generation, and compliance, and to flag leakage and missed capture before savings are lost.
What is patient leakage in health system pharmacy?
Patient leakage is when a patient fills a prescription outside the health system’s own pharmacy network. AI can flag leakage risk early, for example when a discharged patient has not filled a follow-up prescription, so teams can re-engage.
What is VytlAIQ?
VytlAIQ is VytlOne’s AI-powered pharmacy intelligence platform for health system leadership. It unifies data across 340B, outpatient retail, specialty, and clinic-owned pharmacy programs to deliver real-time analytics, predictive insights, and decision support.
See VytlAIQ in action
Health system pharmacy programs are sitting on data that could be driving better decisions today. VytlAIQ was built to unlock that potential across 340B, outpatient retail, specialty, and clinic-owned pharmacy programs in one integrated platform.
Request a demo and see how VytlAIQ gives health system pharmacy leadership the insight to move forward with confidence.
Heather Brooks is a pharmacist and the Vice President of Pharmacy Services Products at VytlOne. She has over 30 years of experience across retail pharmacy, hospital pharmacy, and pharmacy operations. As a pharmacist, Heather believes in AI as a partner in healthcare, working alongside professional judgment. As an operational leader, she’s focused on what that partnership makes possible: leaner processes, faster throughput, and better use of every dollar and every hour.